Wells Fargo & Company Valneva Se Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VALN
# of Institutions
13Shares Held
654KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$2.12 Million0.17% of portfolio
-
Alpha Centric Advisors LLC San Juan, PR88.3KShares$528,6290.51% of portfolio
-
Ironwood Investment Management LLC Boston, MA25KShares$149,8810.1% of portfolio
-
Morgan Stanley New York, NY1.98KShares$11,8540.0% of portfolio
-
Ridgewood Investments LLC550Shares$3,2940.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $414M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...